Background Rotavirus is a leading cause of childhood gastroenteritis and death worldwide.
Methods We studied healthy infants approximately 6 to 12 weeks old who were randomly …

Background Rotavirus gastroenteritis causes many deaths in infants in sub-Saharan Africa.
Because rotavirus vaccines have proven effective in developed countries but had not been …

Background Rotavirus vaccine has proved effective for prevention of severe rotavirus
gastroenteritis in infants in developed countries, but no efficacy studies have been done in …

Background Despite preventive vaccines for oncogenic human papillomaviruses (HPVs),
cervical intraepithelial neoplasia (CIN) is common, and current treatments are ablative and can …

Background A vaccine against SARS-CoV-2 is of high urgency. Here the safety and
immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of …

… In this book, Michael Dallas describes how value management provides the means to
articulate and deliver best value, while risk management provides assurance that the set-up and …

Glutamine, described as a “conditionally essential” amino acid for critically ill patients, has not
been routinely added to parenteral amino acid formulations for critically ill neonates and is …

OBJECTIVES: To investigate safety, efficacy, and immunogenicity of live quadrivalent rotavirus
vaccine (QRV) containing human-bovine (WC3) reassortant rotavirus serotypes G1, G2, …

Purpose: Clinical responses with programmed death (PD-1) receptor–directed antibodies
occur in about 20% of patients with advanced head and neck squamous cell cancer (HNSCCa)…

Background Pediatric use of pneumococcal conjugate vaccines (PCV) has been associated
with significant decrease in disease burden. However, disease caused by non-vaccine …